Global Payments diskutieren
Global Payments
WKN: 603111 / Symbol: GPN / Name: Global Payments / Aktie / Kommerzielle Dienstleistungen / Large Cap /
88,54 €
-0,07 %
Global Payments Inc. (NYSE: GPN) had its price target raised by analysts at Morgan Stanley from $160.00 to $164.00. They now have an "overweight" rating on the stock.
Ratings data for GPN provided by MarketBeat
Global Payments Inc. (NYSE: GPN) had its price target lowered by analysts at Barclays PLC from $160.00 to $145.00. They now have an "overweight" rating on the stock.
Ratings data for GPN provided by MarketBeat
Global Payments Inc. (NYSE: GPN) had its price target lowered by analysts at TD Cowen from $160.00 to $152.00. They now have a "buy" rating on the stock.
Ratings data for GPN provided by MarketBeat
Global Payments Inc. (NYSE: GPN) had its price target lowered by analysts at Monness Crespi & Hardt from $175.00 to $165.00. They now have a "buy" rating on the stock.
Ratings data for GPN provided by MarketBeat
Global Payments Inc. (NYSE: GPN) had its price target lowered by analysts at Citigroup Inc. from $163.00 to $155.00. They now have a "buy" rating on the stock.
Ratings data for GPN provided by MarketBeat
Global Payments Inc. (NYSE: GPN) had its price target lowered by analysts at TD Cowen from $152.00 to $125.00. They now have a "buy" rating on the stock.
Ratings data for GPN provided by MarketBeat
Global Payments Inc. (NYSE: GPN) had its price target lowered by analysts at Evercore ISI from $170.00 to $160.00. They now have an "outperform" rating on the stock.
Ratings data for GPN provided by MarketBeat
Global Payments Inc. (NYSE: GPN) had its price target lowered by analysts at Keefe, Bruyette & Woods from $150.00 to $140.00. They now have an "outperform" rating on the stock.
Ratings data for GPN provided by MarketBeat
Global Payments Inc. (NYSE: GPN) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $172.00 price target on the stock.
Ratings data for GPN provided by MarketBeat
Neueste Beiträge
AI_MarketMaestro in Novartis AG ADR diskutieren